PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies

PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies

PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and evaluation of suspected recurrence. The goal of this 6-part series of review articles is to provide practical information to providers and imaging professional...

Full description

Bibliographic Details
Main Authors:	Ahmed Ebada Salem, Harsh R. Shah, Matthew F. Covington, Bhasker R. Koppula, Gabriel C. Fine, Richard H. Wiggins, John M. Hoffman, Kathryn A. Morton
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Cancers
Subjects:	imaging FDG positron emission tomography PET lymphoma leukemia
Online Access:	https://www.mdpi.com/2072-6694/14/23/5941

Similar Items

PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies
by: Bhasker R. Koppula, et al.
Published: (2022-05-01)

PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology
by: Richard H. Wiggins, et al.
Published: (2022-05-01)

PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors
by: Gabriel C. Fine, et al.
Published: (2022-06-01)

PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies
by: Matthew F. Covington, et al.
Published: (2022-05-01)

PET-CT in Clinical Adult Oncology—IV. Gynecologic and Genitourinary Malignancies
by: Ahmed Ebada Salem, et al.
Published: (2022-06-01)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
by: Yassine Al Tabaa, et al.
Published: (2021-10-01)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
by: Vijay Mistry, et al.
Published: (2023-01-01)

How to Do a PET/CT Scan and Not Glow in the Dark
by: Srijaya Reddy, et al.
Published: (2015-04-01)

What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours
by: Janusch Blautzik, et al.
Published: (2019-12-01)

Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
by: Francesco Giammarile, et al.
Published: (2019-11-01)

A Case of Chronic Neutrophilic Leukemia Incidentally Detected by <sup>18</sup>F-FDG PET/CT
by: Miju Cheon, et al.
Published: (2021-04-01)

[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients
by: Marius E. Mayerhoefer, et al.
Published: (2020-05-01)

Quantitative FDG PET Assessment for Oncology Therapy
by: Kenji Hirata, et al.
Published: (2021-02-01)

The Relatıonshıp Between Pet Ct And Tumor Features In Patıents Wıth Breast Cancer
by: Yasin Sezgin, et al.
Published: (2022-07-01)

Positron Emission Tomography (PET) in Oncology
by: Andrea Gallamini, et al.
Published: (2014-09-01)

Molecular Imaging with PET/CT in Oncology
by: Pejman Farde esfehani, et al.
Published: (2012-04-01)

[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases
by: Laura Evangelista, et al.
Published: (2022-10-01)

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
by: Aino Rajamäki, et al.
Published: (2023-01-01)

Current state of oncologic 18F-FDG PET/CT in Japan: A nationwide survey
by: Hajime Ichikawa, et al.
Published: (2021-07-01)

P.67 The Effects of Chemotherapy on Arterial Inflammation Assessed by ¹⁸FDG PET-CT in Patients with Lymphoma
by: Constantinos Anagnostopoulos, et al.
Published: (2020-12-01)

Uncommon Variants of Mature T-Cell Lymphomas (MTCLs): Imaging and Histopathologic and Clinical Features with Updates from the Fourth Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms
by: Ahmed Ebada Salem, et al.
Published: (2021-10-01)

Application of FDG-PET/CT in Radiation Oncology
by: Jun eLi, et al.
Published: (2013-04-01)

An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
by: Ahmed Ebada Salem, et al.
Published: (2021-11-01)

Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system
by: Pedro Fragoso Costa, et al.
Published: (2022-08-01)

FDG-PET in mantle cell lymphoma involving skin
by: Mehmet Sönmez, et al.
Published: (2010-12-01)

Beyond lymph nodes: 18F-FDG PET/CT in detection of unusual sites of extranodal lymphoma
by: Amal Ibrahim Ahmed Othman, et al.
Published: (2019-09-01)

Diagnostic Value of Composite and Simplified FDG-PET/CT Scores in Polymyalgia Rheumatica and the Influence of Recent Glucocorticoid Treatment—A Retrospective Diagnostic Cohort Study
by: Louise Schouborg Brinth, et al.
Published: (2023-01-01)

Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma
by: Woo Hee Choi, et al.
Published: (2023-09-01)

Diagnostic Accuracy of PET/CT in Detecting Aggressiveness of Lymphoma Based on Sub Uptake
by: Sana waqar, et al.
Published: (2023-04-01)

Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT
by: Francesca Tutino, et al.
Published: (2023-05-01)

The Efficiency of Respiratory-gated 18F-FDG PET/CT in Lung Adenocarcinoma: Amplitude-gating Versus Phase-gating Methods
by: Yoshiyuki Kitamura, et al.
Published: (2017-01-01)

Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics
by: Eun Ji Han, et al.
Published: (2022-01-01)

Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/ Cotswolds Meeting Criteria
by: Kayako Isohashi, et al.
Published: (2015-07-01)

Clinical Impact of <sup>18</sup>F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review
by: Annachiara Arnone, et al.
Published: (2020-12-01)

Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT
by: Esra Arslan, et al.
Published: (2022-05-01)

Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas
by: Hye Lim Park, et al.
Published: (2019-11-01)

Clinical value of 18F-FDG PET/CT in the management of HIV-associated lymphoma
by: Qi Liu, et al.
Published: (2023-01-01)

Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence
by: David Tonnelet, et al.
Published: (2021-04-01)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
by: Melikşah Bayar, et al.
Published: (2021-05-01)

Incremental Value of FDG PET/CT in Aggressive High Grade B Cell lymphoma with TdT Expression
by: NIKITA SAMPATHIRAO, et al.
Published: (2021-01-01)